Skip to main navigation Skip to search Skip to main content

Improved Transition Management of Adolescents and Young Adults With Allergy and/or Asthma: An EAACI Task Force Report on a Follow‐Up European Survey

  • N. Atzert
  • , C. Gore
  • , R. C. Knibb
  • , C. Alviani
  • , E. Angier
  • , K. Blumchen
  • , P. Comberiati
  • , B. Duca
  • , A. DunnGalvin
  • , T. Garriga‐Baraut
  • , M. H. Gowland
  • , B. Egmose
  • , E. Khaleva
  • , C. G. Mortz
  • , H. Pite
  • , O. Pfaar
  • , M. Podesta
  • , S. Sanchez Garcia
  • , A. F. Santos
  • , G. Roberts
  • M. Vazquez Ortiz*
*Corresponding author for this work
  • Department of Allergy and Clinical Immunology Kinderspital Zurich Zurich Switzerland
  • Section of Inflammation, Repair and Development National Heart and Lung Institute Imperial College London United Kingdom
  • The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UK.
  • Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology Goethe University Frankfurt am Main Germany
  • grid.5395.a 0000 0004 1757 3729 Department of Clinical and Experimental Medicine, Section of Paediatrics University of Pisa Pisa Italy; grid.448878.f 0000 0001 2288 8774 Department of Clinical Immunology and Allergology I.M. Sechenov First Moscow State Medical University Moscow Russia
  • Department of Child and Adolescent Health Mater Dei Hospital Msida Malta
  • Paediatrics and Child Infectious Diseases, First Moscow State Medical University, Russia.
  • Grup d'Investigació "Creixement i Desenvolupament", Institut de Recerca de l'Hospital Universitari Vall d'Hebron (VHIR), Barcelona, Spain.
  • Allergy Action, St Albans, UK.
  • Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • University of Southampton, Faculty of Medicine
  • CEDOC, Chronic Diseases Research Center, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Department of Otorhinolaryngology, Head and Neck Surgery Section of Rhinology and Allergy University Hospital Marburg Philipps‐Universität Marburg Marburg Germany
  • EAACI Patient Organisation Committee (POC), Zurich, Switzerland
  • Allergy Department, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain.
  • Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.
  • David Hide Asthma and Allergy Centre Isle of Wight NHS Trust Newport UK

Research output: Contribution to journalArticlepeer-review

2   Link opens in a new tab Citations (SciVal)
4 Downloads (Pure)

Abstract

Background: Adolescents and young adults (AYA) with asthma and allergies have unexpectedly high mortality and morbidity. A survey in 2019 amongst healthcare professionals (HCPs) in Europe highlighted significant gaps in transition care, which negatively impacts patients' outcomes. Since then, an evidence‐based guideline and practical toolbox for effective transition of AYA with asthma and allergies have been published. Aims: To assess HCPs' perspectives, practice and challenges on transition care for AYA with asthma and allergies, including the impact of the recent guideline, potential differences across countries and changes since 2019. Methods: Cross‐sectional online survey‐based study. European HCP managing AYA with allergies and/or asthma were invited to participate in May–June 2023. Results: 511 responses were collected. Amongst respondents, 60%–70% were familiar with the guideline and toolbox, and found them helpful. At least for selected patients, 50%–85% of respondents adhered to some guideline recommendations and initiatives/resources for transition care such as simplifying medication regimes, seeing AYA on their own or producing transition reports. We observed improvements compared to 2019 in areas such as prioritising transition, training, assessment of psychosocial issues and transition readiness, access to other HCP, transfer and post‐transfer feedback systems. However, 20% of respondents had no transition process and around 50% had no transition‐specific elements. Sixty percent found transition care ‘very’ or ‘moderately challenging’, with transition not being prioritised, time constraints and limited expertise on psychosocial issues as leading problems. Significant differences were observed in transition practice across countries. Conclusion: Despite improvement in training and approach towards transition care, challenges and limitations persist in effectively implementing evidence‐based guidelines. Raising greater awareness about the need for, and the positive impact of high‐quality transition care amongst policy‐makers, HCP, and patients/families remains a key priority to unlock resources for training and effective implementation at a national/international level.
Original languageEnglish
Pages (from-to)1592-1612
Number of pages21
JournalAllergy
Volume80
Issue number6
Early online date17 Jun 2025
DOIs
Publication statusPublished - Jun 2025

Bibliographical note

Copyright © 2025 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Funding

This Task force report was supported by the EAACI under the EAACI Task force ‘Allergic diseases in adolescents and young people, towards better patient centred care’, budget code: 40404, year 2023.

Keywords

  • transition
  • asthma
  • allergy
  • young adults
  • guidelines
  • young people
  • teenager
  • transfer
  • adolescents

Fingerprint

Dive into the research topics of 'Improved Transition Management of Adolescents and Young Adults With Allergy and/or Asthma: An EAACI Task Force Report on a Follow‐Up European Survey'. Together they form a unique fingerprint.

Cite this